Prudential PLC Mesoblast LTD Transaction History

Prudential PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$5.74 - $7.42 $8.56 Million - $11.1 Million	-1,491,414 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.67 - $5.88 $5,613 - $7,067	1,202 Added 0.08%	1,491,414 $7.46 Million
Q3 2018 Nov 14, 2018	SELL	$5.75 - $8.16 $205,614 - $291,793	-35,759 Reduced 2.34%	1,490,212 $12.2 Million
Q2 2018 Aug 14, 2018	SELL	$5.27 - $6.21 $33,533 - $39,514	-6,363 Reduced 0.42%	1,525,971 $8.39 Million
Q4 2017 Feb 14, 2018	SELL	$4.91 - $7.23 $14,572 - $21,458	-2,968 Reduced 0.19%	1,532,334 $8.95 Million
Q3 2017 Nov 14, 2017	SELL	$5.4 - $7.41 $34,192 - $46,920	-6,332 Reduced 0.41%	1,535,302 $8.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,541,634	1,541,634 $12.2 Million

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.